Risultati ricerca pubblicazioni

The Usefulness of Scintigraphic Studies in the Assessment of Asymptomatic Bowel Disease in Patients with Primary Antibody Diseases

pubblicato su: JOURNAL OF CLINICAL MEDICINE - 2020
Milito Cinzia, Cinetto Francesco, Megna Valentina, Spadaro Giuseppe, Quinti Isabella, Liberatore Mauro

Mucosal healing in Crohn's disease: new insights

pubblicato su: EXPERT REVIEW OF GASTROENTEROLOGY & HEPATOLOGY - 2020
Cucchiara Salvatore, D'Arcangelo Giulia, Isoldi Sara, Aloi Marina, Stronati Laura

Treat-to-Target in Pediatric Inflammatory Bowel Disease: What Does the Evidence Say?

pubblicato su: PAEDIATRIC DRUGS - 2020
D'Arcangelo G., Aloi M.

Enteroscopy in children and adults with inflammatory bowel disease

pubblicato su: WORLD JOURNAL OF GASTROENTEROLOGY - 2020
Nardo Giovanni Di, Esposito Gianluca, Ziparo Chiara, Micheli Federica, Masoni Luigi, Villa Maria Pia, Parisi Pasquale, Manca Maria Beatrice, Baccini Flavia, Corleto Vito Domenico

Copper-containing amine oxidase purified from lathyrus sativus as a modulator of human neutrophil functions

pubblicato su: INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE - 2020
Pietrangeli P., Capuozzo E., Mateescu M. A., Marcocci L.

Inflammatory Bowel Disease and Acute Coronary Syndromes: From Pathogenesis to the Fine Line Between Bleeding and Ischemic Risk

pubblicato su: INFLAMMATORY BOWEL DISEASES - 2020
Pepe Martino, Carulli Eugenio, Forleo Cinzia, Moscarelli Marco, Di Cillo Ottavio, Bortone Alessandro Santo, Nestola Palma Luisa, Biondi-Zoccai Giuseppe, Giordano Arturo, Favale Stefano

International prospective observational study investigating the disease course and heterogeneity of paediatric-onset inflammatory bowel disease: the protocol of the PIBD-SETQuality inception cohort study

pubblicato su: BMJ OPEN - 2020
Aardoom M. A., Kemos P., Tindemans I., Aloi M., Koletzko S., Levine A., Turner D., Veereman G., Neyt M., Russell R. K., Walters T. D., Ruemmele F. M., Samsom J. N., Croft N. M., de Ridder L.

Protocol for a multinational risk-stratified randomised controlled trial in paediatric Crohn's disease: methotrexate versus azathioprine or adalimumab for maintaining remission in patients at low or high risk for aggressive disease course

pubblicato su: BMJ OPEN - 2020
Harris R. E., Aloi M., de Ridder L., Croft N. M., Koletzko S., Levine A., Turner D., Veereman G., Neyt M., Bigot L., Ruemmele F. M., Russell R. K.

© Università degli Studi di Roma "La Sapienza" - Piazzale Aldo Moro 5, 00185 Roma